Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients-Reference-Cited by-同舟云学术

Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients

Published:2014-11 Issue: Volume:111 Page:53-59
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

van der Ree Meike H.,van der Meer Adriaan J.,de Bruijne Joep,Maan Raoel,van Vliet Andre,Welzel Tania M.,Zeuzem Stefan,Lawitz Eric J.,Rodriguez-Torres Maribel,Kupcova Viera,Wiercinska-Drapalo Alcija,Hodges Michael R.,Janssen Harry L.A.,Reesink Hendrik W.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference33 articles.

1. The functions of animal microRNAs;Ambros;Nature,2004

2. A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C;Backus;Clin. Gastroenterol. Hepatol.,2011

3. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib;Bai;J. Biol. Chem.,2009

4. MicroRNAs: genomics, biogenesis, mechanism, and function;Bartel;Cell,2004

5. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection;Bihrer;Am. J. Gastroenterol.,2011

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease;Clinical and Experimental Medicine;2024-09-11

2. Advances in MicroRNA Therapeutics: from Preclinical to Clinical Studies;Human Gene Therapy;2024-08-16

3. Nanocarriers: Exploring the Potential of Oligonucleotide Delivery;Current Drug Delivery;2024-06-24

4. Chitosan nanocarriers for non-coding RNA therapeutics: A review;International Journal of Biological Macromolecules;2024-04

5. Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review;International Journal of Molecular Sciences;2024-03-24